AKO Capital Edwards Lifesciences Corp Transaction History

Ako Capital LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$57.54 - $76.95 $43.4 Million - $58 Million	-753,568 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $3.92 Million - $6.06 Million	-74,855 Reduced 9.04%	753,568 $142 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $13.3 Million - $15.2 Million	184,924 Added 28.74%	828,423 $193 Million
Q3 2019 Nov 06, 2019	BUY	$61.55 - $75.43 $4.51 Million - $5.52 Million	73,245 Added 12.84%	643,499 $142 Million
Q2 2019 Aug 05, 2019	BUY	$55.74 - $64.41 $6.24 Million - $7.21 Million	111,903 Added 24.41%	570,254 $105 Million
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $8.63 Million - $11.5 Million	180,170 Added 64.77%	458,351 $87.7 Million
Q4 2018 Feb 06, 2019	BUY	$46.41 - $56.94 $2.8 Million - $3.44 Million	60,369 Added 27.72%	278,181 $42.6 Million
Q3 2018 Nov 06, 2018	SELL	$45.7 - $58.03 $1.17 Million - $1.48 Million	-25,524 Reduced 10.49%	217,812 $37.9 Million
Q2 2018 Aug 09, 2018	BUY	$42.45 - $51.3 $10.3 Million - $12.5 Million	243,336 New	243,336 $35.4 Million

1,341

467M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ako Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Ako Capital LLP and Ako Capital with notifications on news.